about
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...
Read More
78.84
2.42
(3.17%)
135.6K
XNAS Volume
XNAS 18 Sep, 2025 12:44 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Arcellx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..